Showing results (31-40 of 396) with videos related to
Sort By:
Pageof 40
Metabolic Syndrome and Related Disorders|March 29, 2008
PPARgamma agonists and vascular risk factors: potential effects on cardiovascular diseaseSunil Asnani, Pierre Theuma, Vivian A FonsecaDiabetes Spectrum : a Publication of the American Diabetes Association|August 7, 2015
Update on Safety Issues Related to Antihyperglycemic TherapyGandahari Rosa A Carpio, Vivian A FonsecaTreatments in Endocrinology|September 28, 2006
The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitusAbu R Vasudevan, Alassia Burns, Vivian A FonsecaHeart Failure Clinics|September 25, 2012
Glucose control and cardiovascular outcomes in individuals with diabetes mellitus: lessons learned from the megatrialsNicholas A Avitabile, Ajaz Banka, Vivian A FonsecaEndocrinology and Metabolism Clinics of North America|March 9, 2005
Potential cardiovascular benefits of insulin sensitizersBiju P Kunhiraman, Ali Jawa, Vivian A FonsecaComprehensive Therapy|January 1, 2003
Effects of thiazolidinediones on cardiovascular risk factorsBiswanath P Gouda, Sunil Asnani, Vivian A FonsecaJournal of Diabetes and Its Complications|June 29, 2021
Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetesAlshaima Alhinai, Keyur Patel, Vivian A Fonseca, et al.Cardiology Clinics|October 22, 2008
Dipeptidyl peptidase-4 as a new target of action for type 2 diabetes mellitus: a systematic reviewJavaid H Wani, Jennifer John-Kalarickal, Vivian A FonsecaKidney International|June 3, 2011
Combination inhibition of the renin-angiotensin system: is more better?Michelle W Krause, Vivian A Fonseca, Sudhir V ShahBMJ Open Diabetes Research & Care|October 22, 2021
Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitusQian Shi, Yilu Lin, Vivian A Fonseca, et al.Pageof 40